MARSHALL WACE, LLP - LUMIRADX LTD ownership

LUMIRADX LTD's ticker is and the CUSIP is G5709L117. A total of 28 filers reported holding LUMIRADX LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LUMIRADX LTD
ValueSharesWeighting
Q3 2022$172,000
-72.3%
168,400
-27.7%
0.00%
-100.0%
Q2 2022$621,000
-59.2%
232,867
-8.1%
0.00%
-66.7%
Q1 2022$1,522,000
-32.5%
253,4260.0%0.00%
-25.0%
Q4 2021$2,254,000
+7.5%
253,4260.0%0.00%
-55.6%
Q3 2021$2,096,000253,4260.01%
Other shareholders
LUMIRADX LTD shareholders Q4 2021
NameSharesValueWeighting ↓
CVS HEALTH Corp 5,352,106$14,237,00011.80%
Empery Asset Management, LP 23,799$23,0000.12%
Senvest Management, LLC 2,249,409$2,024,0000.07%
Covalent Partners LLC 27,500$26,0000.03%
Alpine Global Management, LLC 89,512$81,0000.02%
LMR Partners LLP 200,600$534,0000.01%
LITTLEJOHN & CO LLC 19,634$18,0000.01%
KIM, LLC 125,000$113,0000.01%
MMCAP International Inc. SPC 42,976$41,0000.00%
BLOOM TREE PARTNERS, LLC 10,255$9,0000.00%
View complete list of LUMIRADX LTD shareholders